6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neuropsychiatric Disorders and Brain Function
Disruptions in brain circuitry often underlie complex psychiatric symptoms, making it essential to examine neurobiological foundations of mental illness. Neuropsychiatric disorders and brain function are deeply interwoven, with conditions such as schizophrenia, Parkinson’s disease, bipolar disorder, and Tourette syndrome demonstrating intricate links between behavior and neural pathways. Innovations in neuroimaging, genomics, and electrophysiology allow deeper exploration into brain function and dysfunction. These insights inform not only diagnostics but also treatment, with options like neuromodulation and targeted pharmacotherapy gaining traction. Understanding how neurotransmitter imbalances and neural connectivity contribute to psychiatric symptoms opens the door to more personalized and effective interventions.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States